US Broker Ratings

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a 48.56% Potential Downside Amidst Strong Revenue Growth

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare technology sector, has been attracting attention from investors due to its robust revenue growth and..

Charles River Laboratories (CRL) Stock Analysis: Navigating Market Dynamics with Strategic Collaborations

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a pivotal player in the healthcare sector, specifically within the Diagnostics & Research industry. With a market..

HealthEquity, Inc. (HQY): Investor Outlook Reveals 37.87% Potential Upside

HealthEquity, Inc. (NASDAQ: HQY) stands out in the healthcare sector, offering a unique blend of technology-enabled services that cater to both consumers and employers in the..

iRhythm Technologies, Inc. (IRTC) Investor Outlook: A Growth-Driven Medical Device Innovator with a 5.92% Upside Potential

iRhythm Technologies, Inc. (NASDAQ: IRTC) is a digital healthcare company at the forefront of the medical device industry, specializing in ambulatory cardiac monitoring services. With its..

Akero Therapeutics, Inc. (AKRO) Investor Outlook: Exploring a 67.68% Upside Potential

Akero Therapeutics, Inc. (NASDAQ: AKRO) has captured the attention of investors, particularly those with an eye on the biotechnology sector. With a robust market capitalization of..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A Healthcare Leader with 22.96% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) stands out in the healthcare sector as a key player within the medical instruments and supplies industry. With a market..

Sarepta Therapeutics, Inc. (SRPT)

⚠️ No article content returned.

..

Regencell Bioscience Holdings (RGC) Stock Analysis: Examining the Prospects of a TCM Innovator in Healthcare

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands at the intersection of traditional medicine and modern healthcare, offering investors a unique proposition in the pharmaceutical landscape. As..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: A Biotech Giant with 19.53% Potential Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a trailblazer in the biotechnology sector, is attracting significant attention from investors with its promising potential upside of 19.53%. With a..

The Ensign Group, Inc. (ENSG) Stock Analysis: Navigating a 18.5% Revenue Growth in Healthcare

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, is capturing investor attention with its impressive 18.5% revenue growth. As a company..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Strong Revenue Growth and Promising Upside Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biopharmaceutical company specializing in the development and commercialization of proprietary enzymes and devices, has become a focal point for investors..

BrightSpring Health Services, Inc. (BTSG) Stock Analysis: Impressive Revenue Growth with a 29.10% Surge

BrightSpring Health Services, Inc. (BTSG), a prominent player in the healthcare sector, is capturing investor attention with its impressive revenue growth and a solid footing in..

Guardant Health, Inc. (GH) Stock Analysis: A High-Growth Healthcare Innovator with a Promising Upside

Guardant Health, Inc. (NASDAQ: GH) remains a pivotal player in the diagnostics and research industry within the healthcare sector. With a market capitalization of $7.84 billion,..

Cytokinetics, Incorporated (CYTK) Investor Outlook: Exploring a 32.53% Potential Upside with Cutting-Edge Biopharmaceutical Innovations

Cytokinetics, Incorporated (NASDAQ: CYTK) stands out in the biotechnology sector with its pioneering approach to muscle-activating therapies. The company, headquartered in South San Francisco, California, is..

Avidity Biosciences, Inc. (RNA) Stock Analysis: A 44.92% Potential Upside in RNA Therapeutics

Avidity Biosciences, Inc. (NASDAQ: RNA) is capturing significant attention in the biotechnology sector, boasting a compelling 44.92% potential upside, according to analyst ratings. This San Diego-based..

BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: A 71.68% Potential Upside with Robust Revenue Growth

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, is gaining attention from investors seeking growth opportunities in the healthcare industry. With a..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating a High Market Cap with Caution Amid Analyst Skepticism

Medpace Holdings, Inc. (NASDAQ: MEDP), a stalwart in the healthcare sector, particularly within the diagnostics and research industry, commands significant attention from investors with its robust..

Doximity, Inc. (DOCS) Stock Analysis: Revenue Growth and Analyst Ratings Boost Investor Interest

Doximity, Inc. (NYSE: DOCS), a leading U.S.-based digital platform for medical professionals, has captured the attention of investors in the healthcare sector. With a robust market..

Exact Sciences Corporation (EXAS) Stock Analysis: Healthcare Innovator with 15.71% Upside Potential

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare sector, has garnered significant attention for its innovative approach in the diagnostics and research industry...

ICON plc (ICLR) Stock Report: Assessing the 11.58% Potential Upside in Healthcare Giant

ICON plc (NASDAQ: ICLR), a leader in the Healthcare sector specializing in Diagnostics & Research, is capturing investor attention with its robust portfolio and potential upside..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds